V 625
Generic Name: nelfinavir
Pill imprint V 625 has been identified as Viracept 625 mg.
Viracept is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy.
Viracept 625 mg is not subject to the Controlled Substances Act.
See also related documents.
Viracept Images
- Generic Name:
- nelfinavir
- Imprint:
-
V
625 - Strength:
- 625 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- calcium silicate
crospovidone
magnesium stearate
hypromelloses
triacetin
silicon dioxide
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- ViiV Healthcare
- National Drug Code (NDC):
- 63010-0027
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-5061 | Physicians Total Care Inc (repackager) |
| 54569-5573 | A S Medication Solutions LLC (repackager) |
| 58016-0455 | Southwood Pharmaceuticals Inc (repackager) |
| 35356-0117 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Viracept resources
Search Again
